Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 316

1.

Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL.

Nat Rev Neurol. 2015 Apr 21. doi: 10.1038/nrneurol.2015.57. [Epub ahead of print] Review.

PMID:
25896087
2.

Histological Bulbar Manifestations in the ALS Rat.

Kashlan ON, Kashlan BN, Oh SS, McGinley LM, Chen KS, Kupfer R, Erman A, Sakowski SA, Feldman EL.

Neurodegener Dis. 2015 Mar 24. [Epub ahead of print]

PMID:
25825172
3.

The spectrum of motor neuron diseases: from childhood spinal muscular atrophy to adult amyotrophic lateral sclerosis.

Sakowski SA, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):287-9. doi: 10.1007/s13311-015-0349-7. No abstract available.

PMID:
25794940
4.

Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis.

Goutman SA, Chen KS, Feldman EL.

Neurotherapeutics. 2015 Apr;12(2):428-48. doi: 10.1007/s13311-015-0339-9.

PMID:
25776222
5.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.

Kim B, Feldman EL.

Exp Mol Med. 2015 Mar 13;47:e149. doi: 10.1038/emm.2015.3. Review.

6.

Circuits and circuit disorders: approaches to neuromodulation: call for papers and new initiative with the american neurological association and the annals of neurology.

Rosenberg RN, Feldman EL.

JAMA Neurol. 2015 Apr 1;72(4):385. doi: 10.1001/jamaneurol.2015.0117. No abstract available.

PMID:
25730466
7.

The dual roles of immunity in ALS: Injury overrides protection.

Murdock BJ, Bender DE, Segal BM, Feldman EL.

Neurobiol Dis. 2015 May;77:1-12. doi: 10.1016/j.nbd.2015.02.017. Epub 2015 Feb 26. Review.

PMID:
25726748
8.

The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists.

Callaghan BC, Kerber KA, Banerjee M, Feldman EL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Lisabeth LD.

J Neurol Neurosurg Psychiatry. 2015 Jan 20. pii: jnnp-2014-307575. doi: 10.1136/jnnp-2014-307575. [Epub ahead of print] No abstract available.

PMID:
25604430
9.

Autocrine production of igf-I increases stem cell-mediated neuroprotection.

Lunn JS, Sakowski SA, McGinley LM, Pacut C, Hazel TG, Johe K, Feldman EL.

Stem Cells. 2015 May;33(5):1480-9. doi: 10.1002/stem.1933.

PMID:
25532472
10.

Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves.

Hamid HS, Mervak CM, Münch AE, Robell NJ, Hayes JM, Porzio MT, Singleton JR, Smith AG, Feldman EL, Lentz SI.

Ann Clin Transl Neurol. 2014 Oct;1(10):799-812. doi: 10.1002/acn3.119. Epub 2014 Oct 1.

11.

Therapeutic hypothermia and targeted temperature management after cardiac arrest-reply.

Little NE, Feldman EL.

JAMA Neurol. 2014 Dec;71(12):1578. doi: 10.1001/jamaneurol.2014.3128. No abstract available.

PMID:
25486211
12.

BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses.

O'Brien PD, Hur J, Hayes JM, Backus C, Sakowski SA, Feldman EL.

Neurobiol Dis. 2014 Oct 30;73C:348-355. doi: 10.1016/j.nbd.2014.10.015. [Epub ahead of print]

PMID:
25447227
13.

Therapy for diabetic neuropathy: an overview.

Calabek B, Callaghan B, Feldman EL.

Handb Clin Neurol. 2014;126:317-33. doi: 10.1016/B978-0-444-53480-4.00022-9.

PMID:
25410231
14.

Global metabolomic and isobaric tagging capillary liquid chromatography-tandem mass spectrometry approaches for uncovering pathway dysfunction in diabetic mouse aorta.

Filla LA, Yuan W, Feldman EL, Li S, Edwards JL.

J Proteome Res. 2014 Dec 5;13(12):6121-34. doi: 10.1021/pr501030e. Epub 2014 Nov 13.

PMID:
25368974
15.

Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes.

Gallagher KA, Joshi A, Carson WF, Schaller M, Allen R, Mukerjee S, Kittan N, Feldman EL, Henke PK, Hogaboam C, Burant CF, Kunkel SL.

Diabetes. 2015 Apr;64(4):1420-30. doi: 10.2337/db14-0872. Epub 2014 Nov 3.

PMID:
25368099
16.

Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.

Callaghan BC, Feldman EL.

Ann Intern Med. 2014 Nov 4;161(9):674-5. doi: 10.7326/M14-2157. No abstract available.

PMID:
25364890
17.

Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis.

Foerster BR, Carlos RC, Dwamena BA, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Barker PB, Feldman EL, Pomper MG.

Ann Clin Transl Neurol. 2014 Feb;1(2):107-14. doi: 10.1002/acn3.30. Epub 2014 Jan 13.

18.

Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease.

Nguyen TT, Oh SS, Weaver D, Lewandowska A, Maxfield D, Schuler MH, Smith NK, Macfarlane J, Saunders G, Palmer CA, Debattisti V, Koshiba T, Pulst S, Feldman EL, Hajnóczky G, Shaw JM.

Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):E3631-40. doi: 10.1073/pnas.1402449111. Epub 2014 Aug 18.

19.

Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.

Callaghan BC, Kerber KA, Lisabeth LL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Feldman EL.

JAMA Neurol. 2014 Sep;71(9):1143-9. doi: 10.1001/jamaneurol.2014.1279.

20.

Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan.

Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, Feldman EL.

PLoS One. 2014 Jun 30;9(6):e101186. doi: 10.1371/journal.pone.0101186. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk